GBT Guerbet SA

EPA · FR · Healthcare · Medical Devices · guerbet.com

6.680EUR-0.45%Mkt Cap: 91.09M $P/E: —3d ago

Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use i…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap91.09M USD

Enterprise Value438.10M USD

Revenue (TTM)868.12M USD

Gross Profit615.42M USD

Net Income (TTM)-117.75M USD

Revenue/Share63.31 EUR

Last Price6.680 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees2.7K

CountryFR

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)5.44

PEG0.07

EV/EBITDA8.77

EV/Revenue0.50

P/S0.10

P/B0.32

EPS (TTM)-8.91

EPS (Forward)1.23

52W Range

6.6001% of range18.26

52W High18.26 EUR

52W Low6.600 EUR

Profitability

Gross Margin70.89%

Oper. Margin-1.70%

EBITDA Margin5.76%

Profit Margin-13.56%

ROE-40.57%

ROA-11.65%

Growth

Revenue Growth-5.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF88.14M USD

CapEx (TTM)39.79M USD

FCF Margin9.29%

FCF Yield88.56%

Net Debt354.02M USD

Net Debt/EBITDA7.08

Balance Sheet

Debt/Equity1.65

Current Ratio2.49

Quick Ratio1.08

Book Value/Sh21.16 EUR

Cash/Share9.16 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 EUR

Div. Yield—

5Y Avg Yield2.65%

Payout Ratio0.00%

Ex-Div DateJul 1, 2024

Pay Date—

Splits

Last Split4:1

Split DateJan 23, 2014

Analyst Consensus

Rating—

Target (Mean)8.433 EUR

Upside (mean)+26.2%

Target Range8.000 EUR – 9.000 EUR

8.000+26.2% to mean9.000

# Analysts3

Ownership

Shares Out.12.55M

Float5.12M

Insiders63.21%

Institutions4.66%

Technical

SMA 507.632 (-12.5%)

SMA 20010.27 (-34.9%)

Beta0.97

S&P 52W Chg14.58%

Avg Vol (30d)10.88K

Avg Vol (10d)16.25K

Technical Indicators

RSI (14)17.3

MACD-0.2582

MACD Signal-0.2253

MACD Hist.-0.0329

BB Upper7.772 EUR

BB Middle7.232 EUR

BB Lower6.692 EUR

BB Width14.93%

ATR (14)0.1324 EUR

Vol Ratio (20d)2.36x